Synthesis of 5-thiodidehydropyranylcytosine derivatives as potential anti-HIV agents. 2011

Yuichi Yoshimura, and Yoshiko Yamazaki, and Yukako Saito, and Yoshihiro Natori, and Tomozumi Imamichi, and Hiroki Takahata
Faculty of Pharmaceutical Sciences, Tohoku Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan. yoshimura@tohoku-pharm.ac.jp

As a part of our ongoing efforts to identify new anti-HIV agents, a 5'-thiopyrano-nucleoside derivative 4, designed based on 4'-thioD4C 1 and cyclohexenylnucleoside 3, was synthesized. The dihydrothiopyran skeleton of 4 was constructed by the ring closing metathesis of 21 which was synthesized from but-2-yne-1,4-diol. After converting the protecting group from MOM to TBS followed by oxidation, a Pummerer-type thioglycosylation reaction of 24 with persilylated uracil gave the desired 5-thiodihydrothiopyranyluracils 25 and 26 as a mixture of anomers. The conversion of 25 to a cytosine derivative and subsequent deprotection gave a 5-thiodidehydropyranosylcytosine derivative 4 in good yield. The anti-HIV activity of 4 was also evaluated.

UI MeSH Term Description Entries
D011714 Pyrans Pyran
D003596 Cytosine A pyrimidine base that is a fundamental unit of nucleic acids.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013457 Sulfur Compounds Inorganic or organic compounds that contain sulfur as an integral part of the molecule. Sulfur Compound,Compound, Sulfur,Compounds, Sulfur
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Yuichi Yoshimura, and Yoshiko Yamazaki, and Yukako Saito, and Yoshihiro Natori, and Tomozumi Imamichi, and Hiroki Takahata
May 1996, Farmaco (Societa chimica italiana : 1989),
Yuichi Yoshimura, and Yoshiko Yamazaki, and Yukako Saito, and Yoshihiro Natori, and Tomozumi Imamichi, and Hiroki Takahata
January 2005, Nucleosides, nucleotides & nucleic acids,
Yuichi Yoshimura, and Yoshiko Yamazaki, and Yukako Saito, and Yoshihiro Natori, and Tomozumi Imamichi, and Hiroki Takahata
June 2012, Bioorganic & medicinal chemistry letters,
Yuichi Yoshimura, and Yoshiko Yamazaki, and Yukako Saito, and Yoshihiro Natori, and Tomozumi Imamichi, and Hiroki Takahata
March 1982, Il Farmaco; edizione scientifica,
Yuichi Yoshimura, and Yoshiko Yamazaki, and Yukako Saito, and Yoshihiro Natori, and Tomozumi Imamichi, and Hiroki Takahata
June 2007, European journal of medicinal chemistry,
Yuichi Yoshimura, and Yoshiko Yamazaki, and Yukako Saito, and Yoshihiro Natori, and Tomozumi Imamichi, and Hiroki Takahata
January 2023, Journal of biomolecular structure & dynamics,
Yuichi Yoshimura, and Yoshiko Yamazaki, and Yukako Saito, and Yoshihiro Natori, and Tomozumi Imamichi, and Hiroki Takahata
February 2005, The Journal of pharmacy and pharmacology,
Yuichi Yoshimura, and Yoshiko Yamazaki, and Yukako Saito, and Yoshihiro Natori, and Tomozumi Imamichi, and Hiroki Takahata
April 2011, European journal of medicinal chemistry,
Yuichi Yoshimura, and Yoshiko Yamazaki, and Yukako Saito, and Yoshihiro Natori, and Tomozumi Imamichi, and Hiroki Takahata
December 2018, Molecules (Basel, Switzerland),
Yuichi Yoshimura, and Yoshiko Yamazaki, and Yukako Saito, and Yoshihiro Natori, and Tomozumi Imamichi, and Hiroki Takahata
June 2021, Bioorganic chemistry,
Copied contents to your clipboard!